Later this afternoon the Senate will vote to confirm Scott Gottlieb as the next U.S. Food and Drug Administration (FDA) commissioner. What does this mean for scientists and science-based policymaking at the FDA? His conflicts of interest are certainly an indication that the pharmaceutical industry will benefit more from his tenure than Americans’ health. Read more >
May 9, 2017 4:24 PM EDT
April 7, 2017 3:44 PM EDT
President Trump’s nominee to head the U.S. Food & Drug Administration (FDA), Scott Gottlieb, faced the Senate in his nomination hearing on Wednesday, during which he implied that delayed implementation of the science-based nutrition facts label revision would be possible if he is confirmed.
Yes, you read that right. Read more >